Related Experiment Video
Updated: Jul 5, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Trypanocidal structure-activity relationship for cis- and trans-methylpluviatolide
R da Silva1, J Saraiva, S de Albuquerque
1Núcleo de Ciências Exatas e Tecnológicas, Universidade de Franca, Avenida Dr. Armando Salles de Oliveira, 2001, 14404-600 Franca, SP, Brazil.
The trans-methylpluviatolide enantiomer showed significant activity against Trypanosoma cruzi, the parasite causing Chagas disease. This finding offers potential for new drug development against parasitic infections.
Area of Science:
- Pharmacology
- Parasitology
- Organic Chemistry
Background:
- Trypanosoma cruzi causes Chagas disease, a neglected tropical illness.
- Methylpluviatolides are natural compounds with potential biological activities.
- Understanding stereoisomer-specific activity is crucial for drug development.
Purpose of the Study:
- To evaluate the in vitro trypanocidal activity of cis- and trans-methylpluviatolides against Trypanosoma cruzi.
- To assess the cytotoxicity and mechanism of action of these compounds.
- To determine the specific activity of individual enantiomers of trans-methylpluviatolide.
Main Methods:
- In vitro assays against trypomastigote forms of Trypanosoma cruzi.
- Enzymatic assay of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase (gGAPDH).
- Cytotoxicity assessment using the MTT method on LLC-MK2 cells.
- Chiral High-Performance Liquid Chromatography (HPLC) for enantiomer separation.
Main Results:
- The mixture of trans-methylpluviatolide stereoisomers exhibited trypanocidal activity (IC50 ≈ 89.3 µM).
- Separation by chiral HPLC yielded (+) and (-)-enantiomers; only the (-)-enantiomer was active (IC50 ≈ 18.7 µM).
- Trans-methylpluviatolide showed low cytotoxicity (IC50 ≈ 6.53 mM) and did not inhibit gGAPDH, peroxide, or NO production.
Conclusions:
- The (-)-trans-methylpluviatolide enantiomer possesses significant trypanocidal activity.
- This enantiomer demonstrates a favorable safety profile with low cytotoxicity.
- Methylpluviatolides represent a promising class of compounds for developing new anti-Trypanosoma cruzi therapies.
Related Concept Videos
Disubstituted Cyclohexanes: cis-trans Isomerism
In cyclohexane, the substituents can occupy different positions generating distinct isomers.
Antiprotozoal Agents
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Inhibitors of Bacterial DNA Synthesis

